Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Aug 2026.
- Largest single sale: $641K (10,000 shares) of Xenon Pharmaceuticals Inc. on Aug 11, 2026. Filing
- Last sale before this period: Jun 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | Director | May 22, 2015 | Aug 13, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 11, 2026, Xenon Pharmaceuticals Inc.: sold 10,000 shares for $641K, no plan disclosed. 1 filing: 1
- Jun 1, 2026, Xenon Pharmaceuticals Inc.: 2,645 shares vested; 1,416 shares withheld by the company for taxes. 1 filing: 1
- May 12, 2026, Xenon Pharmaceuticals Inc.: 3,500 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.